this post was submitted on 06 Jul 2023
32 points (100.0% liked)

News

327 readers
1 users here now

Breaking news and current events worldwide.

founded 1 year ago
 

The first approved drug to slow the progression of the illness will come with a strong safety warning about potentially life-threatening side effects.

you are viewing a single comment's thread
view the rest of the comments
[–] agentshags 2 points 1 year ago

Leqembi, from Japanese drugmaker Eisai and U.S.-based drugmaker Biogen, targets a type of protein in the brain called beta-amyloid, long thought by scientists to be one of the underlying causes of Alzheimer’s disease.